RSS

Proteus

The US Food and Drug Administration (FDA) has rejected the first medication that combines drugs with a digital sensor that measures medication adherence more

News

Tom Homer, Telstra, looks at the maturing market of digital health and partnerships between life science and technology companies more

Opinion

Aripiprazole has been combined with an ingestible sensor to create a combination product, Abilify, which has New Drug Application (NDA) acceptance from the Food and Drug Administration (FDA) more

News